Table 1 Patient characteristics at baseline and after propensity score matching.

From: Impact of infection-related admission in patients with heart failure: a 10 years national cohort study

 

Propensity score matching

Before

After

Total (N = 52,092)

Control (N = 26,046)

Infection (N = 26,046)

ASMD

Total (N = 31,318)

Control (N = 15,659)

Infection (N = 15,659)

ASMD

Age

69.75 ± 15.58

64.64 ± 15.91

74.86 ± 13.42

0.695

71.71 ± 13.92

71.10 ± 13.21

72.31 ± 14.58

0.087

Male

28,163 (54.06)

15,401 (59.13)

12,762 (49.00)

0.204

16,290 (52.01)

8194 (52.33)

8096 (51.70)

0.013

Diabetes mellitus

22,295 (42.80)

8743 (33.57)

13,552 (52.03)

0.380

14,063 (44.90)

6813 (43.51)

7250 (46.30)

0.056

Hypertension

38,803 (74.49)

17,557 (67.41)

21,246 (81.57)

0.329

24,275 (77.51)

12,012 (76.71)

12,263 (78.31)

0.038

Hyperlipidemia

14,956 (28.71)

8508 (32.67)

6448 (24.76)

0.176

9089 (29.02)

4678 (29.87)

4411 (28.17)

0.038

Coronary artery disease

28,288 (54.30)

14,614 (56.11)

13,674 (52.50)

0.073

16,938 (54.08)

8480 (54.15)

8458 (54.01)

0.003

Previous MI

8395 (16.12)

4502 (17.28)

3893 (14.95)

0.064

4597 (14.68)

2276 (14.53)

2321 (14.82)

0.008

Previous PCI

7627 (14.64)

4493 (17.25)

3134 (12.03)

0.148

4073 (13.01)

2039 (13.02)

2034 (12.99)

0.001

Previous CABG

1670 (3.21)

961 (3.69)

709 (2.72)

0.055

1009 (3.22)

521 (3.33)

488 (3.12)

0.012

Previous CRT/ICD

144 (0.28)

83 (0.32)

61 (0.23)

0.016

82 (0.26)

42 (0.27)

40 (0.26)

0.003

Peripheral artery disease

1170 (2.25)

394 (1.51)

776 (2.98)

0.099

736 (2.35)

345 (2.20)

391 (2.50)

0.019

Valvular heart disease

10,028 (19.25)

5294 (20.33)

4734 (18.18)

0.055

6201 (19.80)

3164 (20.21)

3037 (19.39)

0.020

Atrial fibrillation

10,583 (20.32)

4996 (19.18)

5587 (21.45)

0.056

6511 (20.79)

3246 (20.73)

3265 (20.85)

0.003

Ischemic stroke

7611 (14.61)

2296 (8.82)

5315 (20.41)

0.333

4419 (14.11)

2009 (12.83)

2410 (15.39)

0.074

ICH

1402 (2.69)

294 (1.13)

1108 (4.25)

0.194

682 (2.18)

280 (1.79)

402 (2.57)

0.053

CKD

10,996 (21.11)

3700 (14.21)

7296 (28.01)

0.343

6890 (22.00)

3268 (20.87)

3622 (23.13)

0.055

ESRD

4579 (8.79)

1641 (6.30)

2938 (11.28)

0.177

3055 (9.75)

1488 (9.50)

1567 (10.01)

0.017

COPD

14,530 (27.89)

4175 (16.03)

10,355 (39.76)

0.549

8446 (26.97)

3827 (24.44)

4619 (29.50)

0.114

Asthma

5146 (9.88)

1580 (6.07)

3566 (13.69)

0.258

3120 (9.96)

1425 (9.10)

1695 (10.82)

0.058

Liver cirrhosis

1628 (3.13)

537 (2.06)

1091 (4.19)

0.123

973 (3.11)

452 (2.89)

521 (3.33)

0.025

Peptic ulcers

11,647 (22.36)

4148 (15.93)

7499 (28.79)

0.313

7005 (22.37)

3359 (21.45)

3646 (23.28)

0.044

Gastrointestinal bleeding

10,413 (19.99)

3603 (13.83)

6810 (26.15)

0.312

6200 (19.80)

2920 (18.65)

3280 (20.95)

0.058

Malignancy

38,867 (74.61)

17,385 (66.75)

21,482 (82.48)

0.368

23,967 (76.53)

11,798 (75.34)

12,169 (77.71)

0.056

Medication history

 ACEI/ARB/ARNI

25,877 (49.68)

13,646 (52.39)

12,231 (46.96)

0.109

15,700 (50.13)

7972 (50.91)

7728 (49.35)

0.031

 Beta-blocker

21,847 (41.94)

12,263 (47.08)

9584 (36.80)

0.210

12,833 (40.98)

6581 (42.03)

6252 (39.93)

0.043

 Ivabradine

60 (0.12)

32 (0.12)

28 (0.11)

0.005

35 (0.11)

19 (0.12)

16 (0.10)

0.006

 MRA

8967 (17.21)

3969 (15.24)

4998 (19.19)

0.105

5358 (17.11)

2576 (16.45)

2782 (17.77)

0.035

 Statin

12,876 (24.72)

7818 (30.02)

5058 (19.42)

0.248

7471 (23.86)

3883 (24.80)

3588 (22.91)

0.044

 Diuretics

22,195 (42.61)

8754 (33.61)

13,441 (51.60)

0.370

13,886 (44.34)

6712 (42.86)

7174 (45.81)

0.059

 Digoxin

6221 (11.94)

2875 (11.04)

3346 (12.85)

0.056

3848 (12.29)

1906 (12.17)

1942 (12.40)

0.007

 H-ISDN

1050 (2.02)

306 (1.17)

744 (2.86)

0.120

588 (1.88)

271 (1.73)

317 (2.02)

0.022

 Antiplatelet

24,805 (47.62)

12,737 (48.90)

12,068 (46.33)

0.051

14,837 (47.38)

7427 (47.43)

7410 (47.32)

0.002

 Anticoagulant

4978 (9.56)

2682 (10.30)

2296 (8.82)

0.050

3144 (10.04)

1641 (10.48)

1503 (9.60)

0.029

 Antiarrhythmic

5818 (11.17)

2578 (9.90)

3240 (12.44)

0.081

3469 (11.08)

1710 (10.92)

1759 (11.23)

0.010

 OHA

14,164 (27.19)

5921 (22.73)

8243 (31.65)

0.201

9067 (28.95)

4442 (28.37)

4625 (29.54)

0.026

 Insulin

7408 (14.22)

1888 (7.25)

5520 (21.19)

0.408

4024 (12.85)

1757 (11.22)

2267 (14.48)

0.097

 NSAID

13,371 (25.67)

6533 (25.08)

6838 (26.25)

0.027

8407 (26.84)

4202 (26.83)

4205 (26.85)

0.000

 Steroid

10,298 (19.77)

3052 (11.72)

7246 (27.82)

0.413

5758 (18.39)

2596 (16.58)

3162 (20.19)

0.093

 Colchicine

3082 (5.92)

1323 (5.08)

1759 (6.75)

0.071

1876 (5.99)

914 (5.84)

962 (6.14)

0.013

  1. ASMD absolute standardized mean difference, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, CRT cardiac resynchronization therapy, ICD implantable cardioverter-defibrillator, ICH intracerebral hemorrhage, CKD chronic kidney disease, ESRD end-stage renal disease, COPD chronic obstructive pulmonary disease, ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers, ARNI angiotensin receptor-neprilysin inhibitor, MRA mineralocorticoid receptor antagonists, H-ISDN hydralazine–isosorbide dinitrate, OHA oral hypoglycemic agents, NSAID non-steroidal anti-inflammatory drugs.